2002 CCHP PREFERRED DRUG LIST - Contra Costa County

anti-arrhythmic drug. Some risk of proarrhythmia (less than other Na+ blockers). Minimal effect on ECG. Parenteral use only. Losartan Competitive . angiotensin II (AT1) receptor antagonist; inhibits vasoconstriction, aldosterone release and hypertrophic growth. 1st line treatment of . CHF. and . HTN. Fewer side effects than ACE inhibitors ... ................
................